Discover small cap biotech stocks
We are a small team of investors building a high performing ASX small cap stock portfolio and sharing our investing journey with our readers for free.
Finfeed if following on from one of Australia’s most successful biotech and life sciences fund managers to select and invest in early to mid-stage ASX listed biotechs.
| Stocks |
Date of Initial Coverage
|
Initial Entry Price
|
Last Price
|
Portfolio Weighting | Shares Held | Macro Theme | Actively Sharing | Highest Point |
Performance from Initial Entry
|
|---|---|---|---|---|---|---|---|---|---|
| ALA | 1645102800 18-Feb-2022 | $0.038 | $0.036 |
3.51%
|
13,631,579 | Biotech |
|
45% | -5% |
| DXB | 1629036000 16-Aug-2021 | $0.200 | $0.115 |
2.07%
|
2,525,000 | Biotech |
|
140% | -43% |
| Stocks |
Date of Initial Coverage
|
Initial Entry Price
|
Last Price
|
Portfolio Weighting | Shares Held | Macro Theme | Actively Sharing | Highest Point |
Performance from Initial Entry
|
|---|---|---|---|---|---|---|---|---|---|
| ALA | 1645102800 18-Feb-2022 | $0.038 | $0.036 |
3.51%
|
13,631,579 | Biotech |
|
45% | -5% |
| DXB | 1629036000 16-Aug-2021 | $0.200 | $0.115 |
2.07%
|
2,525,000 | Biotech |
|
140% | -43% |
Looking for a stock that has been removed from our Portfolio? Visit our “bottom drawer” portfolio and past investments page.
The past performance is not and should not be taken as an indication of future performance. Caution should be exercised in assessing past performance. This product, like all other financial products, is subject to market forces and unpredictable events that may adversely affect future performance.
We invest in around 10 carefully selected ASX small cap companies per year. We share our commentary as these companies execute on their business plan over time.
Companies we are invested in can pay us a fee to publicly share our commentary on how our investment is progressing.
Discover Small Cap
Biotech Stocks
Join thousands of other Investors following our stock commentary for Free